HOME ABOUT US ADVERTISE SUBSCRIBE SITE MAP HELP CONTACT WORK FOR US  
Friday
3 September 2010
Make BTN my HomePage 
 




HealthLinx jumps 113% on UK debut


SHARES in ovarian cancer diagnostic company HealthLinx rocketed yesterday on news of today’s debut of the OvPlex test in the United Kingdom and the Republic of Ireland.



You are not logged in or not authorised to view this page.

Get Your FREE 30 Day Trial Now!

First Name
Last Name
Phone
Email Address
Confirm Email

OR

Members Login Here

Email Address
Password
 

  • Note: Cookies must be enabled to log in
  • Forgotten Your Password? Click here
  • Having problems? View our help page here.

Click here to read the rest of today's news stories.



 
RELATED LINKS

[COMPANY]
-HEALTHLINX LIMITED [HTX]
[SECTION]
-Distribution Deals
-New Partnerships
-Health Biotech
-General
[RELATED STORY]
-OvPlex to hit UK market next year: HealthLinx
-HealthLinx poised to kick off larger OvPlex trial
-Novogen delays Ovature data analysis
-Capital Briefs: Prima BioMed raises $2.5M
-Market Pulse: debuts shine like diamonds
-Bio Briefs: AtCor, TetraQ, HealthLinx, Benitec, Solagran
-HealthLinx OvPlex 2G study underway
-HealthLinx progresses diagnostics
-South Korea trial adds 220 linxs




Company Search




Story Search

Advanced Search

UPCOMING
EVENTS
WA BioBeers
ABIC 2010 - Bridging Biology and Business
14th International Biotechnology Symposium & Exhibition 2010
BIO India Partnering Conference 2010
OZBIO2010
2010 Livestock Biotech Summit
  View all events


TODAY'S NEWS

Avexa bioadvisors on board


Progen-Medigen progress muparfostat


Approval boosts Unilife


Bio Briefs: Benitec, Tissue Therapies, Epichem and more


South Korea trial adds 220 linxs


Aspermont reports profit


Clinuvel adds to family


pSivida lifted on FDA news


Pharmaxis reps dance Quintiles-style


In Silico: More signs the FDA is toughening up